Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2023 After Market Close on March 13, 2023
March 06, 2023 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Dyadic to Present at Roth Investor Conference and Upcoming Industry Events
March 01, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., March 01, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Biopharmaceuticals Contract Manufacturing Market Research 2023-2030 'Reports Insights'
February 27, 2023 07:00 ET
|
REPORTSINSIGHTS CONSULTING PVT LTD
New York, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The Biopharmaceuticals Contract Manufacturing Market is projected to grow at a CAGR of 5.6% from 2023 to 2030, reaching a value of USD 27.6 Billion by...
Kymanox Acquires EU based Anteris Medical and Anteris Helvetia
February 02, 2023 13:59 ET
|
Kymanox
Morrisville, North Carolina USA, Holzkirchen, Germany and Küssnacht a.R., Switzerland, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Kymanox Corporation (“Kymanox”), a professional services company...
Dyadic Announces Sale of Equity Interest in Alphazyme
January 19, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Biologics Market to Experience Substantial Growth of USD 596.65 Billion by 2029, Size, Share, Trends, Key Drivers, Growth and Opportunity Analysis
January 16, 2023 01:14 ET
|
Data Bridge Market Research
SYDNEY, Jan. 16, 2023 (GLOBE NEWSWIRE) -- "Biologics Market" is the title of a new report from Data Bridge Market Research. Key growth strategies, drivers, opportunities, key segments, Porter's Five...
Celltrion and Rani Therapeutics Partner on Development of Oral Monoclonal Antibody Treatment
January 09, 2023 08:30 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Biopharmaceutical Executive Eric Strati joins Gift of Life Biologics as Chief Executive Officer
January 02, 2023 10:00 ET
|
Gift of Life Marrow Registry
BOCA RATON, Fla., Jan. 02, 2023 (GLOBE NEWSWIRE) -- Gift of Life Biologics announced today that accomplished biopharmaceutical leader Eric Strati, Pharm.D. MBA has joined the firm as its Chief...
Chemical Computing Group and Discngine Join Forces
December 22, 2022 15:00 ET
|
Chemical Computing Group
MONTREAL, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Chemical Computing Group ULC ("CCG") announced today that it has acquired Discngine SAS ("Discngine"), a company that develops state-of-the-art IT...
Rapid Micro Biosystems® Announces Publication of a Multi-Author Case Study Supporting Fully Automated Colony Counting in Pharmaceutical Microbiology
December 07, 2022 16:30 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company, providing mission critical automation...